Charles University Innovations Prague

Charles University Innovations Prague (CUIP) is the wholly-owned technology transfer subsidiary of Charles University, established to bridge the gap between academic research and commercial application. The company manages the university's extensive intellectual property portfolio, facilitates licensing agreements, and establishes spin-off companies across diverse sectors, with a primary focus on life sciences and healthcare. CUIP provides professional support for patenting, market analysis, and business development to transform scientific discoveries into market-ready products. Notable successes include the rapid commercialization of diagnostic kits during the COVID-19 pandemic and the formation of specialized biotech ventures in oncology, immunology, and lipidomics. By acting as a bridge between researchers and the global market, CUIP ensures that academic innovations achieve significant societal and economic impact.